Skip to main content
. 2010 Jul 2;5(7):e11421. doi: 10.1371/journal.pone.0011421

Figure 2. Success of flecainide-induced cardioversion in different β1AR genotypes, A, P389 polymorphism, B, P49 polymorphism, C, combination genotype of P389 and P49 variants.

Figure 2

Dashed line marks the average cardioversion rate of 39%. *p<0.05 vs. other variants.